We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Cells Harvested From Urine to Enable Earlier Kidney Disease Detection

By LabMedica International staff writers
Posted on 20 Mar 2024
Print article
Image: Cells harvested from urine offers potential for non-invasive diagnostic testing of kidney disease (Photo courtesy of 123RF)
Image: Cells harvested from urine offers potential for non-invasive diagnostic testing of kidney disease (Photo courtesy of 123RF)

Detecting kidney disease late can lead to severe and even life-threatening issues. Now, new research has found that the genes expressed in human cells harvested from urine closely match those in the kidney, suggesting that these cells could offer a non-invasive approach to better understanding kidney health. This discovery could allow the diagnosis of kidney problems without doing biopsies, making it possible to detect kidney disease earlier and more easily.

A team of scientists led by the University of Manchester (Manchester, UK) used a method called transcriptomics to measure the levels of about 20,000 genes in each cellular sediment sample of urine. Transcriptomics helps scientists see which genes are active or inactive, providing insights into how cells adapt to changes in their environment. This molecular-level understanding can lead to more accurate diagnoses and better patient outcomes. The team also had access to the world's largest collection of human kidney samples from surgeries or biopsies, known as the Human Kidney Tissue Resource, at the University of Manchester.

The researchers used advanced computational methods to extract both DNA and RNA from the samples and analyze data from previous large-scale studies on blood pressure. They discovered that a low level of a particular gene in the kidney could be a cause of high blood pressure. This gene, ENPEP, produces an enzyme called aminopeptidase and is crucial for blood pressure regulation. It was among the 399 genes identified in the study whose levels in the kidney have a direct impact on blood pressure readings.

“This study shows that using cutting edge technology we are able to combine different unique datasets together using genetics as a connector,” said Professor Maciej Tomaszewski, Chair of Cardiovascular Medicine at The University of Manchester, who led the study. “One of the most exciting findings of that is we discover how cells harvested from urine have the potential to provide a glimpse into the molecular operation of the human kidney. That gives us an exciting avenue of research for non-invasive diagnostic testing.”

“There is a well-known link between the heart and the kidneys in regulating blood pressure,” said Professor Bryan Williams, Chief Scientific and Medical Officer at the British Heart Foundation which funded the study. “This study uses cutting-edge scientific techniques to analyze genes present in kidney cells that are normally expelled in the urine. Analyzing these cells could reveal which genes may be playing a key role in people with high blood pressure, and could potentially offer clinicians a new, non-invasive way to help diagnose those with kidney disease early on.”

Related Links:
University of Manchester

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.